Neuropathology

Disease

1 paper

  • Animals1

Funding

19 grants since 2016

National Institute on AgingUS$23.5mCanadian Institutes of Health Research (CIHR) Project GrantCA$1.8mAlzheimer's Association

Latest

Nov 2025: 13Dec 2025: 126Jan 2026: 35Feb 2026: 12Mar 2026: 19Apr 2026: 17May 2026: 15Jun 2026: 13Jul 2026: 22Aug 2026: 29Sep 2026: 22Oct 2026: 9332 in 12 months
Nutrients

Diet’s link to dementia differed by gene variant in older adults

In one genetic group, each extra diet-score point was linked to lower relative Alzheimer’s dementia risk over time (hazard ratio 0.82).In one genetic group, each extra diet-score point was linked to lower relative Alzheimer’s dementia risk over time (hazard ratio 0.82).

Cohort study of 745 older adultsAll-cause dementia

Limit: Questionnaire-based diet estimates may misclassify adherence and distort genotype-specific associations

Acta Neuropathologica

Human brain vessels show distinct states in small vessel disease

Researchers identified three vessel states across disease severity by analysing 11,409 vessel fragments from post-mortem brain tissue from 20 cases.Researchers identified three vessel states across disease severity by analysing 11,409 vessel fragments from post-mortem brain tissue from 20 cases.

Cross-sectional study of 20 peopleMechanisms
Aging Cell

A compound is linked to better cognition mainly in male mice

In six-month-old mice with accelerated aging, ER272 was linked to better cognition and preserved markers of new brain cells in males, but showed limited effects in…In six-month-old mice with accelerated aging, ER272 was linked to better cognition and preserved markers of new brain cells in males, but showed limited effects in females.

Experiments in miceInterventions
medRxiv

Lifestyle trial found similar Alzheimer’s blood marker changes

A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.

Preprint: randomised trial in 1,260 peopleAlzheimer's disease